The Lactobacillus plantarum P-8 Probiotic Microcapsule Prevents DSS-Induced Colitis through Improving Intestinal Integrity and Reducing Colonic Inflammation in Mice

Han Wang,Yaxuan Sun,Xuan Ma,Tianyu Yang,Feng Wang

DOI: https://doi.org/10.3390/nu16071055

IF: 5.9

2024-04-05

Nutrients

Abstract:Probiotics, recognized as beneficial and active microorganisms, often face challenges in maintaining their functionality under harsh conditions such as exposure to stomach acid and bile salts. In this investigation, we developed probiotic microcapsules and assessed their protective effects and underlying mechanisms in a murine model of dextran sulfate sodium (DSS)-induced colitis using male C57BL/6J mice. The administration of the probiotic microcapsules significantly mitigated body weight loss, prevented colon length shortening, decreased the disease activity index scores, and reduced histopathological scores in mice with DSS-induced colitis. Concurrently, the microencapsulated probiotics preserved intestinal barrier integrity by upregulating the expressions of tight junction proteins ZO-1 and occludin, as well as the mucus layer component MUC-2. Moreover, the treatment with probiotic microcapsules suppressed the activation of the NLRP3 inflammasome signaling pathway in the context of DSS-induced colitis. In conclusion, these findings support the utilization of probiotic microcapsules as a potential functional food ingredient to maintain the permeability of the intestinal barrier and alleviate colonic inflammation in UC.

nutrition & dietetics

What problem does this paper attempt to address?

The problem this paper attempts to address is: by developing and evaluating the protective effects and potential mechanisms of probiotic microcapsules in a DSS (dextran sulfate sodium)-induced mouse colitis model, to explore whether probiotic microcapsules can improve intestinal barrier function, reduce colonic inflammation, and serve as a potential functional food ingredient for the treatment of ulcerative colitis (UC).

Specifically, the main objectives of the study include:
1. **Improving the survival rate and stability of probiotics**: Protecting the survival rate of probiotics in the gastrointestinal tract through microencapsulation technology, especially in environments with low pH and high bile salt concentrations.
2. **Alleviating DSS-induced colitis symptoms**: Evaluating the therapeutic effects of probiotic microcapsules on DSS-induced colitis in mice, including improvements in weight loss, colon length shortening, disease activity index (DAI) scores, and histopathological scores.
3. **Enhancing intestinal barrier function**: Investigating the protective effects of probiotic microcapsules on the integrity of the intestinal barrier, particularly by upregulating the expression of tight junction proteins (such as ZO-1 and occludin) and mucus layer components (such as MUC-2).
4. **Inhibiting inflammatory responses**: Exploring the regulatory effects of probiotic microcapsules on the NLRP3 inflammasome signaling pathway, thereby reducing colonic inflammation.

Through these objectives, the study aims to provide a new, safe, and effective strategy for the treatment of ulcerative colitis.